质子抑制剂的使用和更年期妇女的事件高血压
Ahmed I Soliman1, Jean Wactawski-Wende1, Amy E Millen1
1Department of Epidemiology and Environmental Health University at Buffalo-SUNY Buffalo NY USA.
Journal of the American Heart Association
|June 27, 2025
概括
质子抑制剂 (PPI) 的使用可能会增加更年期妇女的高血压风险. 较长时间使用PPI与逐渐增加的风险相关,这表明这种常见药物的剂量依赖关系.
科学领域:
- 心血管健康 心血管健康
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 质子抑制剂 (PPI) 通过影响氧化的产生,可能会影响血压调节.
- 使用PPI与新发高血压的发展之间的关联尚不清楚.
研究的目的:
- 调查质子抑制剂使用与绝经后妇女发生高血压之间的关系.
- 检查PPI使用时间和患高血压的风险之间的关联.
主要方法:
- 分析了来自妇女健康倡议观察研究的64,720名妇女的队列.
- 事件高血压通过自我报告来评估,使用Cox比例危险模型来估计风险.
- 用PPI对血压变化的影响在三年内使用线性回归来评估.
主要成果:
- 使用质子抑制剂与患高血压风险增加17%有关.
- 随着更长时间的PPI使用,观察到逐渐增加高血压风险的显著趋势 (趋势P<0.001).
- 与非使用者相比,PPI的新用户在三年内显示了平均静脉压的显著增加.
结论:
- 质子抑制剂的使用与更年期妇女诊断高血压的风险增加有关.
- 高血压的风险显示出与使用PPI持续时间相关的显著趋势.
- 需要进一步的研究来证实这些发现,并阐明潜在的机制.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
532
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
532
Antihypertensive Drugs: Direct Renin Inhibitors
845
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
845
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
259
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
259
Antihypertensive Drugs: Potassium-Sparing Diuretics
785
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
785
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
574
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
574
Antihypertensive Drugs: Vasodilators
654
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
654


